RT Journal Article
SR Electronic
A1 Hoyle, Brian
T1 Once-Weekly Exenatide Allows Sustained HbA1C Control
JF MD Conference Express
YR 2013
FD SAGE Publications
VO 13
IS 17
SP 9
OP 9
DO 10.1177/155989771317004
UL http://mdc.sagepub.com/content/13/17/9.1.abstract
AB This article reports on the 3-year results of the Efficacy of Exenatide Once-Weekly and Once-Daily Insulin Glargine in Patients With Type 2 Diabetes Treated With Metformin Alone or in Combination With Sulfonylurea [DURATION-3; NCT00641056] open-label, randomized, controlled trial. Sustained HbA1C, greater weight reduction, and less frequent hypoglycemia were evident up to 3 years in subjects with type 2 diabetes mellitus compared with insulin glargine [Malloy J et al. EASD 2013 (abstr 2)].